T

Telomir Pharmaceuticals Inc
NASDAQ:TELO

Watchlist Manager
Telomir Pharmaceuticals Inc
NASDAQ:TELO
Watchlist
Price: 4.3 USD -5.49% Market Closed
Market Cap: 127.3m USD
Have any thoughts about
Telomir Pharmaceuticals Inc?
Write Note

Income Statement

Earnings Waterfall
Telomir Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-19.8m USD
Operating Income
-19.8m USD
Other Expenses
-9.4m USD
Net Income
-29.2m USD

Income Statement
Telomir Pharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(1)
(1)
(3)
(3)
(4)
(13)
(15)
(20)
Selling, General & Administrative
(0)
(0)
(1)
(2)
(2)
(3)
(5)
(9)
Research & Development
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(3)
Other Operating Expenses
0
0
0
0
0
(7)
(7)
(7)
Operating Income
(1)
N/A
(1)
-49%
(3)
-106%
(3)
-27%
(4)
-18%
(13)
-226%
(15)
-15%
(20)
-34%
Pre-Tax Income
Interest Income Expense
0
0
(0)
(1)
(2)
(6)
(10)
(9)
Non-Reccuring Items
0
0
0
0
(7)
0
0
0
Pre-Tax Income
(1)
N/A
(1)
-49%
(3)
-116%
(4)
-54%
(13)
-209%
(19)
-44%
(25)
-32%
(29)
-17%
Net Income
Income from Continuing Operations
(1)
(1)
(3)
(4)
(13)
(19)
(25)
(29)
Net Income (Common)
(1)
N/A
(1)
-49%
(3)
-116%
(4)
-54%
(13)
-209%
(19)
-44%
(25)
-32%
(29)
-17%
EPS (Diluted)
-0.03
N/A
-0.05
-67%
-0.1
-100%
-0.15
-50%
-0.48
-220%
-0.69
-44%
-0.84
-22%
-0.98
-17%